IL6 and melanoma: A significant difference between IL-6 supernatant concentrations was observed between the control leukocyte and those stimulated with recombinant HLA-G at 100ng (p<0.001) and the control leukocyte and those stimulated with LEVs from melanoma patients in a proportion 1:10 (p=0.01).